CME Group/$CME
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CME Group
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Ticker
$CME
Sector
Primary listing
Employees
3,760
Headquarters
Website
CME Group Metrics
BasicAdvanced
$93B
25.06
$10.33
-
$10.60
1.93%
Price and volume
Market cap
$93B
52-week high
$290.79
52-week low
$212.38
Average daily volume
1.9M
Dividend rate
$10.60
Financial strength
Current ratio
1.019
Quick ratio
0.021
Long term debt to equity
12.331
Total debt to equity
12.331
Dividend payout ratio (TTM)
102.42%
Interest coverage (TTM)
25.29%
Profitability
EBITDA (TTM)
4,547
Gross margin (TTM)
100.00%
Net profit margin (TTM)
58.59%
Operating margin (TTM)
65.51%
Effective tax rate (TTM)
22.27%
Revenue per employee (TTM)
$1,710,000
Management effectiveness
Return on assets (TTM)
1.74%
Return on equity (TTM)
13.61%
Valuation
Price to earnings (TTM)
25.056
Price to revenue (TTM)
14.467
Price to book
3.36
Price to tangible book (TTM)
-34.62
Price to free cash flow (TTM)
22.658
Free cash flow yield (TTM)
4.41%
Free cash flow per share (TTM)
11.423
Dividend yield (TTM)
4.10%
Forward dividend yield
1.93%
Growth
Revenue change (TTM)
11.17%
Earnings per share change (TTM)
13.89%
3-year revenue growth (CAGR)
10.92%
10-year revenue growth (CAGR)
7.01%
3-year earnings per share growth (CAGR)
8.67%
10-year earnings per share growth (CAGR)
11.34%
3-year dividend per share growth (CAGR)
8.10%
10-year dividend per share growth (CAGR)
9.48%
What the Analysts think about CME Group
Analyst ratings (Buy, Hold, Sell) for CME Group stock.
Bulls say / Bears say
Record Q2 trading volumes drove revenue of $1.69 billion and profit of $1.07 billion, with average daily volumes hitting 30.2 million contracts, up 16% year-over-year, beating analyst expectations. (Reuters)
The number of new retail traders rose 57% year-over-year in Q2, boosting record Micros ADV of 4.1 million contracts and diversifying CME’s customer base. (Reuters)
CME’s cryptocurrency trading saw a 136% increase in average daily volume in Q2, led by ether futures, demonstrating strong growth in emerging asset classes. (Reuters)
CME is preparing for competition from BGC Group’s FMX Futures platform entering the U.S. Treasury futures market, which could erode its dominant market share. (Reuters)
In Q1 2025, CME’s EPS of $2.80 narrowly missed estimates by a penny as operating expenses rose 1.1% from elevated technology spending, indicating potential margin compression. (Reuters)
Despite an 18.3% share price gain year-to-date, CME’s stock lags peers Cboe Global (23.4%) and Intercontinental Exchange (21.3%), suggesting limited relative upside. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
CME Group Financial Performance
Revenues and expenses
CME Group Earnings Performance
Company profitability
CME Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept25
CME Group
DividendPayment
$1.25Per share
FAQs
What’s the current market cap for CME Group stock?
CME Group (CME) has a market cap of $93B as of September 16, 2025.
What is the P/E ratio for CME Group stock?
The price to earnings (P/E) ratio for CME Group (CME) stock is 25.06 as of September 16, 2025.
Does CME Group stock pay dividends?
Yes, the CME Group (CME) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $10.6 and the yield is 1.93%. CME Group has a payout ratio of 102.42% on a trailing twelve-month basis.
When is the next CME Group dividend payment date?
The next CME Group (CME) dividend payment is scheduled for September 25, 2025.
What is the beta indicator for CME Group?
CME Group (CME) does not currently have a Beta indicator.